Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of hearing function in patients with type 2 diabetes mellitus and investigation of its relationship with stages of diabetic retinopathy.

Journal of diabetes and metabolic disorders·2025
Same author

Incidence of postoperative retinal detachment and bacterial endophthalmitis in the Swedish national paediatric cataract register and associated risk factors.

Acta ophthalmologica·2025
Same author

Retinal vasculature changes in patients with internal carotid artery stenosis.

International ophthalmology·2024
Same author

Evaluation of lamina cribrosa parameters, nerve fiber thickness, and macular thickness in primary open-angle glaucoma and pseudoexfoliation glaucoma using optical coherence tomography.

International ophthalmology·2024
Same author

Evaluation of the lamina cribrosa after topical latanoprost therapy in primary open-angle glaucoma or ocular hypertension.

Photodiagnosis and photodynamic therapy·2024
Same author

The toxicity assessment of phosmet on development, reproduction, and gene expression in <i>Daphnia magna</i>.

PeerJ·2024

Related Experiment Video

Updated: Apr 26, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

7.7K

Systemic endothelial function in primary open-angle glaucoma.

Mustafa Atas1, Hasan Basri Arifoglu1, Arzu Seyhan Karatepe Hashas1

  • 1Department of Ophthalmology and Vision Science, Kayseri Training and Research Hospital, Sanayi Mah. Atatürk Boulevard Hastane Street, No. 78, 38010 Kayseri, Turkey.

Journal of Ophthalmology
|July 18, 2014
PubMed
Summary
This summary is machine-generated.

Open-angle glaucoma (POAG) patients show normal peripheral vascular endothelial function. Flow-mediated dilation (FMD) measurements indicate POAG is likely a local eye condition, not a systemic disease.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

12.6K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Related Experiment Videos

Last Updated: Apr 26, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

7.7K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

12.6K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.7K

Area of Science:

  • Ophthalmology
  • Cardiology
  • Vascular Biology

Background:

  • Open-angle glaucoma (POAG) is a common optic neuropathy.
  • Systemic vascular endothelial dysfunction is linked to various diseases.
  • Its role in POAG pathogenesis remains unclear.

Purpose of the Study:

  • To evaluate peripheral vascular endothelial function in patients with POAG.
  • To compare endothelial function between POAG cases and healthy controls using flow-mediated dilation (FMD).

Main Methods:

  • A study involving 20 POAG patients and 30 healthy controls.
  • Cardiovascular assessment of endothelial function via brachial artery flow-mediated dilation (FMD) measurement.
  • Standardized occlusion and measurement protocols were employed.

Main Results:

  • Mean FMD was 11.9 ± 4.2% in the POAG group.
  • Mean FMD was 12.3 ± 4.4% in the healthy control group.
  • No statistically significant difference in FMD was observed between groups (P = 0.86).

Conclusions:

  • Peripheral vascular endothelial function is not impaired in individuals with POAG.
  • These findings suggest POAG may primarily be a localized ocular disorder.
  • POAG is unlikely to be a manifestation of a broader systemic vascular disease.